Results 51 to 60 of about 19,730 (233)

Pemikiran Ibnu Qayyim al-Jawziyyah tentang Penggunaan Hadis Da'if dalam Istinbat Hukum

Al-Manahij: Jurnal Kajian Hukum Islam, 2013
Tulisan ini mencoba untuk menganalisis tentang konsep hadis da’if dan konsep tentang pengamalan hadis da’if. Kebanyakan para ulama mengkonsepsikan hadis da’if; “setiap hadis yang tidak terpenuhi unsur-unsur yang ada dalam hadis sahih ataupun ...
Abdul Fatah Idris
doaj   +1 more source

The role of the community pharmacist in medicine information transfer during transitions of care and the impact on associated outcomes: a scoping review

Journal of Pharmacy Practice and Research, EarlyView.
Abstract Background Transitions of care (TOC) between hospital and community settings are high‐risk periods for medication‐related problems (MRPs), often caused by inadequate information transfer between healthcare settings. Community pharmacists are well positioned to support continuity of care; however, they are frequently excluded from the ...
Melanie Bailey, Laetitia Hattingh, Mathew Percival, Henry Ndukwe   +3 more
wiley   +1 more source

Timing of DAA Initiation After Curative Treatment and Its Relationship with the Recurrence of HCV-Related HCC

Journal of Hepatocellular Carcinoma, 2020
Xiuzhu Gao,1,2,* Mengru Zhan,1,* Liquan Wang,3 Yanhua Ding,2 Junqi Niu1 1Department of Hepatology, First Hospital of Jilin University, Changchun, Jilin 130021, People’s Republic of China; 2Phase I Clinical Research Center, The First Hospital of ...
Gao X, Zhan M, Wang L, Ding Y, Niu J
doaj  

Outcomes of pharmacist‐led deprescribing interventions in older adults living in long‐term care facilities: a scoping review

Journal of Pharmacy Practice and Research, EarlyView.
Abstract Background An increase in the ageing population across long‐term care facilities (LTCFs) has led to an increased risk of polypharmacy. Pharmacist‐led deprescribing (PLD) can reduce these risks but there are limitations to its widespread uptake.
Sefunmi Odetola, Eileen Willis, Katrina Lane‐Krebs, Ashlyn Sahay   +3 more
wiley   +1 more source

Sustained virological response in HCV patients receiving antiviral treatment at a teaching centre of northern India

Journal of Family Medicine and Primary Care
In India, it is estimated that 10–24 million people are living with active HCV infection, with a seroprevalence of 0.09% to 2.02% among the healthy population.
Astha, Arti Agrawal, Ayushi Gupta, Priyanka Sahu, Dharmendra Kumar, Pragya Shakya   +5 more
doaj   +1 more source

Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort.

PLoS ONE, 2017
BackgroundReal-life data on access and response to direct antiviral agents (DAA) in HIV-HCV coinfected individuals are lacking.MethodsHCV viremic, HIV-positive patients from Icona and Hepaicona cohorts naïve to DAA by January 2013 were included.
Antonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Francesca Ceccherini-Silberstein, Andrea De Luca, Sergio Lo Caputo, Antonella Castagna, Cristina Mussini, Antonella Cingolani, Alessandro Tavelli, Milensu Shanyinde, Andrea Gori, Enrico Girardi, Massimo Andreoni, Andrea Antinori, Massimo Puoti, Icona Foundation and HepaIcona Study Group   +15 more
doaj   +1 more source

Successful treatment of vertically acquired Hepatitis C in a child using direct‐acting antiviral therapy administered via gastrojejunal tube: A case report

JPGN Reports, EarlyView.
Abstract Hepatitis C virus (HCV) remains a significant global health burden, with vertical transmission being the primary route of infection in children. Direct‐acting antivirals (DAAs) have transformed HCV treatment in pediatrics, but limited data exist on their administration in medically complex children who are dependent on enteral tubes. We report
Connie Chen, Leah Gibson, James Squires
wiley   +1 more source

Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver‐Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral Therapy

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Patients with chronic hepatitis C (CHC) frequently present with steatotic liver disease (SLD) and cardiometabolic risk factors (CMRFs). This study aimed to evaluate the impact of SLD and CMRFs on liver‐related outcomes (LROs) in CHC patients after HCV eradication.
Chung‐Feng Huang, Yi‐Hung Lin, Pei‐Chien Tsai, Ming‐Lun Yeh, Chih‐Wen Wang, Tyng‐Yuan Jang, Po‐Cheng Liang, Yu‐Ju Wei, Nai‐Jen Hou, Ming‐Yen Hsieh, Chao‐Kuan Huang, Tzu‐Chun Lin, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang, Ming‐Lung Yu   +15 more
wiley   +1 more source

Efficacy of Interferonfree treatment for patients with chronic hepatitis C virus

Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, 2019
The new direct-acting antiviral agents (DAA) have revolutionised the treatment of patients with chronic hepatitis C virus (HCV) infection. With the development of new potent DAA and the approval of different DAA combinations, cure rates of HCV infection ...
Valeria Muntean, Adela Ţurcanu, Eugen Tcaciuc   +2 more
doaj  

The Global Parkinson's Disease Genetics (GP2) Genome Browser

Movement Disorders, EarlyView.
Abstract Background Large‐scale sequencing initiatives have generated extensive genomic resources essential for variant interpretation, yet their effective use often requires bioinformatics expertise. To support identification of Parkinson's disease (PD) risk and disease‐causing variants, we developed an open‐access, summary‐level genomic data browser.
Zih‐Hua Fang, Riley H. Grant, Dan Vitale, Carlos F. Hernandez, Samantha Hong, Hampton L. Leonard, Mary B. Makarious, Lara M. Lange, Matthew Solomonson, Peter Heutink, Allison A. Dilliott, Kamalini Ghosh Galvelis, Mike A. Nalls, Andrew B. Singleton, Cornelis Blauwendraat, the Global Parkinson's Genetics Program (GP2)   +15 more
wiley   +1 more source